(Abst.) Residual disability after severe relapse in PwMS treated w/DMT on: November 02, 2018, 07:33:40 am #1 From PubMed, November 2, 2018--"Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy": Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy - PubMed A high rate of incomplete recovery was seen 12 months following severe relapse among RRMS patients and may contribute to the accumulation of long-term disability. PubMed · ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
